Page 19 - Sofinnova Partners News Today

Odyssey Therapeutics raised $168 million in Series B financing, the largest round of funding for a biotech startup this week. Companies developing new technologies in genetic diseases, cancer, and drug research are represented also represented in this week’s recap of life science financings.

Apollo funds are being put toward Haveli’s investments that include the software sector and gaming.

/PRNewswire/ -- Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 14th Annual...

Renowned reproductive health expert Dr. Robert Auerbach, OBGYN, appointed chairman of the board - May Health, formerly AblaCare, changes its name to reflect focus on restoring the lives of those with

HUNTINGTON BEACH, Calif, Sept. 8, 2022 /PRNewswire/ -- Long waiting lists plus overburdened staff and infrastructure - a legacy of the pandemic - highlight a broken healthcare model needing

iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, today announced the appointment of Frances Balkwill, Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, to its Scientific Advisory Board (SAB).

/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that the Company...

BioPharma

Synthace, creators of the world's first digital life science experiment platform, today announced the appointment of Dr. Donald Deieso as the new Chairman of their Board. Dr. Deieso steps into this

DGAP-News: ABIVAX / Key word(s): Miscellaneous ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with...